NCT07895342

Overcoming Immunotherapy Resistance in Hepatocellular Carcinoma

RecruitingNAINTERVENTIONAL

Trial Details

Start: 2026-10Est. Completion: 2028-09

Enrollment target: 16 participants

Locations

Radboud University Medical Center, Nijmegen, Netherlands

Contact

Harm Westdorp, MD, PhDharm.westdorp@radboudumc.nl 0031 243610353

Other microbiome trials you might be interested in

Cabozantinib Combined With Ipilimumab/Nivolumab and TACE in Patients With Hepatocellular CarcinomaPhase 2Recruiting

Hepatocellular CarcinomaHCC

This is a phase 2 single-arm, open-label clinical trial determining efficacy of cabozantinib in combination with ipilimu…

Orange, United StatesEst. completion Jan 31, 2027

View Trial →

Testing the Combination of Pevonedistat With Chemotherapy for Bile Duct Cancer of the LiverPhase 2Recruiting

Metastatic CholangiocarcinomaMetastatic Hepatocellular CarcinomaStage III Hepatocellular Carcinoma AJCC v8Stage III Intrahepatic Cholangiocarcinoma AJCC v8Stage IIIA Hepatocellular Carcinoma AJCC v8Stage IIIA Intrahepatic Cholangiocarcinoma AJCC v8

Apply or Learn More on ClinicalTrials.gov

MicrobiomeTrials does not provide medical advice. Always consult your doctor before joining a clinical trial.